MSD Partners with Briya for Advanced Data Analysis
In an exciting development in the healthcare sector, MSD, a leading pharmaceutical company, has entered a strategic collaboration with Briya, known for its innovative medical data retrieval solutions. This partnership marks a milestone in real-world evidence (RWE) data analysis projects, which play a vital role in advancing understanding in three significant disease areas that MSD is actively involved with.
Utilizing Cutting-Edge Technology for Better Patient Insights
By leveraging Briya's state-of-the-art data platform, MSD can effectively standardize and analyze real-world data accrued from multiple sources. This initiative allows for a comprehensive view of the patient journey in real-time, facilitating a more nuanced understanding of patient experiences and outcomes.
A Statement from MSD's Leadership
MSD Israel's Commercial Operations Director, Udi Cohen, expressed enthusiasm regarding the collaboration, stating, "We are happy to have partnered with Briya on this important initiative. Briya's data curation techniques enhance our ability to analyze clinical data, including complex free text and medical notes, allowing for the generation of valuable patient insights. This will pave the way for significant clinical insights in the future."
Ensuring Data Security and Compliance
The collaboration between MSD and Briya emphasizes not only the potential of advanced data capabilities but also the paramount importance of data security and regulatory compliance. Briya’s platform is designed with the highest standards of data protection, ensuring patient information is handled securely throughout the data analytics process.
A Commitment to Healthcare Innovation
"Our collaboration with MSD signifies a remarkable step towards our mission to support innovative research with our robust data solutions," remarked David Lazerson, CEO, and Co-founder of Briya. He expressed pride in facilitating this RWE project and looks forward to enhancing patient care and outcomes through continued partnership.
The Future of Pharmaceutical Innovation and Research
This partnership is a clear demonstration of how pharmaceutical expertise combined with advanced data capabilities can lead to transformative healthcare solutions. MSD and Briya are dedicated to ongoing innovation, aiming to elevate the field of medical science and make strides in improving patient lives.
About MSD
MSD stands at the forefront of global healthcare, devoted to enhancing the health and well-being of communities worldwide. From pioneering novel therapies that combat diseases to providing assistance to those in need, MSD strives to leave a positive impact on global health.
About Briya
Briya operates a comprehensive healthcare data network that optimizes the potential of patient-level data. Their global approach fosters seamless integrations between various healthcare stakeholders, including hospitals and research organizations. Through secure data-sharing capabilities, Briya enables the standardization and harmonization of important healthcare information.
Contact Information
For inquiries, please reach out to Mor Pecht at mor.pecht@briya.com.
Frequently Asked Questions
What is the main goal of the MSD and Briya collaboration?
The primary aim is to enhance real-world evidence data analysis in critical disease areas, improving patient insights and care.
How does Briya ensure data security?
Briya adheres to stringent data handling protocols that comply with regulatory requirements to protect patient information.
What technologies are utilized in this partnership?
The collaboration leverages cutting-edge data platforms to standardize and analyze real-world healthcare data efficiently.
Who is leading the MSD side of the project?
Udi Cohen, MSD Israel's Commercial Operations Director, is actively involved in this strategic partnership.
What future initiatives can we expect from MSD and Briya?
The partnership aims for ongoing innovation in healthcare research and improved patient outcomes through advanced data solutions.
